Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


16.10.2017

1 Antimicrob Agents Chemother
13 Clin Infect Dis
2 J Antimicrob Chemother
1 J Infect
1 Lancet Respir Med
5 PLoS One
1 Trop Med Int Health
1 Wien Klin Wochenschr


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. DE WELZEN L, Eldholm V, Maharaj K, Manson AL, et al
    Whole transcriptome and genomic analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01461.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. FARHAT MR, Jacobson KR, Franke MF, Kaur D, et al
    Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;65:1364-1370.
    PubMed     Text format     Abstract available

  3. ADU-GYAMFI CG, Snyman T, Hoffmann CJ, Martinson NA, et al
    Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.
    Clin Infect Dis. 2017;65:1356-1358.
    PubMed     Text format     Abstract available

  4. MCKENNA L, Frick M, Lee C, Namutamba D, et al
    A Community Perspective on the Inclusion of Pregnant Women in Tuberculosis Drug Trials.
    Clin Infect Dis. 2017;65:1383-1387.
    PubMed     Text format     Abstract available

  5. DOBLER CC
    Cumulative Incidence and Incidence Rate Ratio for Estimation of Risk of Tuberculosis in Patients With Cancer.
    Clin Infect Dis. 2017;65:1423.
    PubMed     Text format    

  6. VANINO E, Tadolini M, Attard L, Po C, et al
    Systematic Tuberculosis Screening in Asylum Seekers in Italy.
    Clin Infect Dis. 2017;65:1407-1409.
    PubMed     Text format     Abstract available

  7. SIVRO A, McKinnon LR, Yende-Zuma N, Gengiah S, et al
    Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa.
    Clin Infect Dis. 2017;65:819-826.
    PubMed     Text format     Abstract available

  8. SALINAS JL, Armstrong LR, Silk BJ, Haddad MB, et al
    Factors Associated with All-Cause Mortality among Patients with Multidrug-Resistant Tuberculosis - United States, 1993-2013.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. SCHECHTER MC, Bizune D, Kagei M, Machaidze M, et al
    Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
    Clin Infect Dis. 2017 Aug 3. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. MUNOZ L, Santin M, Alcaide F, Ruiz-Serrano MJ, et al
    QuantiFERON(R)-TB Gold In-Tube as a confirmatory test for tuberculin skin test in tuberculosis contact tracing: A non-inferiority clinical trial.
    Clin Infect Dis. 2017 Aug 18. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. BACCANI I, Antonelli A, Galano A, Bartalesi F, et al
    Linezolid-resistant Enterococcus faecalis infection following prolonged low-dosage linezolid treatment for multi-drug-resistant tuberculosis.
    Clin Infect Dis. 2017 Aug 20. doi: 10.1093.
    PubMed     Text format    

  12. DRANCOURT M
    Please, no more gastric aspirate to diagnose pulmonary tuberculosis in children.
    Clin Infect Dis. 2017 Aug 19. doi: 10.1093.
    PubMed     Text format    

  13. ARGUELLO PEREZ E, Seo SK, Schneider WJ, Eisenstein C, et al
    Management of Latent Tuberculosis Infection among Healthcare Workers: 10-year Experience at a Single Center.
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. FLORIDIA M, Ciccacci F, Andreotti M, Hassane A, et al
    Tuberculosis case finding with combined rapid point of care assays (Xpert(R) MTB/RIF and LAM) in HIV-positive individuals starting antiretroviral treatment in Mozambique.
    Clin Infect Dis. 2017 Jul 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  15. VILLELLAS C, Coeck N, Meehan CJ, Lounis N, et al
    Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
    J Antimicrob Chemother. 2017;72:684-690.
    PubMed     Text format     Abstract available

  16. NAGU TJ, Aboud S, Matee MI, Maeurer MJ, et al
    Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw503. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Infect

  17. PEGORIE M, Denning DW, Welfare W
    Estimating the burden of invasive and serious fungal disease in the United Kingdom.
    J Infect. 2017;74:60-71.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  18. THE LANCET RESPIRATORY MEDICIN
    Where are the innovations in tuberculosis drug discovery?
    Lancet Respir Med. 2017 Oct 4. pii: S2213-2600(17)30376.
    PubMed     Text format    


    PLoS One

  19. RICE JP, Seifert M, Moser KS, Rodwell TC, et al
    Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    PLoS One. 2017;12:e0186139.
    PubMed     Text format     Abstract available

  20. RENIERS G, Blom S, Lieber J, Herbst AJ, et al
    Tuberculosis mortality and the male survival deficit in rural South Africa: An observational community cohort study.
    PLoS One. 2017;12:e0185692.
    PubMed     Text format     Abstract available

  21. PATI S, Swain S, Metsemakers J, Knottnerus JA, et al
    Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India.
    PLoS One. 2017;12:e0183966.
    PubMed     Text format     Abstract available

  22. MINDU C, Lopez-Varela E, Alonso-Menendez Y, Mausse Y, et al
    Caretakers' perspectives of paediatric TB and implications for care-seeking behaviours in Southern Mozambique.
    PLoS One. 2017;12:e0182213.
    PubMed     Text format     Abstract available

  23. SCHECHTER MC, Buac K, Adekambi T, Cagle S, et al
    Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB.
    PLoS One. 2017;12:e0182587.
    PubMed     Text format     Abstract available


    Trop Med Int Health

  24. LIN S, Melendez-Torres GJ
    Critical interpretive synthesis of barriers and facilitators to TB treatment in immigrant populations.
    Trop Med Int Health. 2017;22:1206-1222.
    PubMed     Text format     Abstract available


    Wien Klin Wochenschr

  25. FABIAN E, Schneeweiss B, Valentin T, Flick H, et al
    Clinical-Pathological Conference Series from the Medical University of Graz : Case No 162: A 30-year-old woman from Nigeria with fever 3 months postpartum.
    Wien Klin Wochenschr. 2017;129.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: